Tina Cascone

36PUBLICATIONS
289CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGenomics and transcriptomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Sep 18, 2026
CT-based deep foundation model for predicting immune checkpoint inhibitor-induced pneumonitis risk in lung cancer.

|Aug 12, 2026
Biomarkers of nivolumab benefit in resectable non-small cell lung cancer.

|Jul 08, 2026
Unbiased avidity-based isolation of antigen-specific T cells.

|Jul 01, 2026
Improving neoadjuvant and perioperative therapy in non-small-cell lung cancer.

|Apr 23, 2026
Real-World Experience of Tarlatamab in Extensive-Stage Small Cell Lung Carcinoma Showed Promising Systemic and Intracranial Efficacy With Higher Neurologic Toxicity.

|Mar 16, 2026
Improving Anti-CTLA-4 Therapies through Peptide Masking and Fragment Crystallizable Non-fucosylation: Preclinical Characterization of Three Novel Antibodies.

Amy Jhatakia, Xin Sun, Alessandra Vaccaro

Pageof 6

Frequent Collaborators

17 joint publications

Don L Gibbons

17 joint publications

John Victor Heymach

16 joint publications

Jianjun Zhang

11 joint publications

Jack J Lee